Arch Virol. 2009 Jun 19. [Epub ahead of print]
Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
Wu R, Chen Q,...
2 results in 0.0386 seconds.
-
Giuseppe started a topic Arch Virol. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.in VaccinesArch Virol. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
-
Vaccine. Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.
Vaccine. 2009 May 21;27(24):3189-94. Epub 2009 Apr 10.
Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza.
Kwon...